|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Non-cash ground rent and amortization of other intangibles | |||||
| Amortization of debt premiums, discounts, and financing costs | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale of investment properties | |||||
| Impairment and other losses | |||||
| Gain on insurance recoveries | |||||
| Share-based compensation expense | |||||
| Deferred interest expense | |||||
| Changes in assets and liabilities: | |||||
| Accounts and rents receivable | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of investment properties | |||||
| Capital expenditures | |||||
| Proceeds from sale of investment properties | |||||
| Proceeds from property insurance | |||||
| Performance guaranty payments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from mortgage debt modification | |||||
| Payoff of mortgage debt | |||||
| Principal payments of mortgage debt | |||||
| Principal payments on finance leases | |||||
| Proceeds from Corporate Credit Facility Term Loans | |||||
| Principal payments on Corporate Credit Facility Term Loans | |||||
| Proceeds from draws on the Revolving Credit Facility | |||||
| Payments on the Revolving Credit Facility | |||||
| Proceeds from Senior Notes | |||||
| Principal payments of 2020 Senior Notes | |||||
| Repurchase of 2020 Senior Notes | |||||
| Payment of loan fees and issuance costs | |||||
| Payment of loan modification fees | |||||
| Repurchase of common shares | |||||
| Redemption of Operating Partnership Units | |||||
| Dividends and dividend equivalents | |||||
| Shares redeemed to satisfy tax withholding on vested share-based compensation | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, at beginning of year | |||||
| Cash and cash equivalents and restricted cash, at end of year | |||||
| The following represents cash paid during the periods presented for the following: | |||||
| Cash paid for interest, net of $0.5 million, $3.2 million and $0.9 million of capitalized interest for the years ended December 31, 2025, 2024 and 2023, respectively. | |||||
| Cash paid (received) for income taxes (refunds) | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| Accrued capital expenditures | |||||
| Distributions payable | |||||
| Supplemental disclosure of cash flow information: | |||||
| The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets to the amount shown in the consolidated statements of cash flows: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...